Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:LPC P-20:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003911 AN006422 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 Bacterial cells Eggerthella lenta Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003911 AN006422 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 Bacterial cells Fusobacterium nucleatum Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006419 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Bifidobacteria Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006419 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Clostridium Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006419 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Escherichia coli Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003910 AN006419 Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. Bacterial cells Streptococcus Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003792 AN006234 Untargeted lipidomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Maple syrup urinary disease University of Colorado Denver LC-MS
ST003792 AN006234 Untargeted lipidomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Metabolic disease University of Colorado Denver LC-MS
  logo